Bristol-Myers Squibb Company Files Trademark Application for "ALAGNIVO" for Treatment of Multiple Diseases
Bristol-Myers Squibb Company has filed a trademark application for "ALAGNIVO" for pharmaceutical preparations that treat a wide range of diseases, including obesity, cardiovascular diseases, and cancer. The application, made available to the public on September 25, 2025, lists the trademark goods and services class codes as 005. The goods and services listed include pharmaceutical preparations for human use for treating various diseases, as well as immunosuppressants, immunotherapies, and monoclonal antibodies. The application was made by Marilyn F. Kelly on behalf of the company and is currently pending.
Key Takeaways:
- The trademark application "ALAGNIVO" is for pharmaceutical preparations that treat multiple diseases, including obesity, cardiovascular diseases, and cancer.
- The application lists the trademark goods and services class codes as 005, indicating that the goods and services are related to pharmaceuticals and medical treatments.
- The goods and services listed in the application include pharmaceutical preparations for human use, immunosuppressants, immunotherapies, and monoclonal antibodies.
- The application was made available to the public on September 25, 2025, and is currently pending.
- The registrant information for this application is Marilyn F. Kelly, representing Bristol-Myers Squibb Company.
- The goods and services listed in the application are for the treatment of various diseases, including obesity, cardiovascular diseases, and cancer.
Statistics:
- The trademark goods and services class codes for this application are 005.
- The goods and services listed in the application include pharmaceutical preparations for human use for treating 17 different diseases.
- The application lists 7 specific types of pharmaceutical preparations, including immunosuppressants and immunotherapies.
Sources:
https://www.newsrx.com/newsrelease/20250925PR112.gif
https://www.bristolmyerssquibb.com